This is Why Investors are Pushing Into Psychedelics

Psychedelics have gone mainstream. For one researchers at New York University found psilocybin mushrooms caused a “rapid and sustained” reduction in anxiety and depression in patients with cancer, as reported by the Financial Post.  Two, there’s rapidly changing consumer attitudes towards psychedelics, just as we saw with cannabis around the world. Three, with plenty of … Continue reading “This is Why Investors are Pushing Into Psychedelics”